Prokidney PROK
NASDAQ PROK
$1.72 +0.01 (+0.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Prokidney (PROK) Selling, General & Administrative (2021 - 2026)

Updated

Prokidney (PROK) posted Selling, General & Administrative of $12.43 million for Q2 2026, down 11.5% from $14.05 million a year earlier but up 9.8% from the prior quarter.

Analysis

Prokidney (PROK) Selling, General & Administrative (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Prokidney was $47.12 million, down 18.7% year-over-year; for FY2025, it was $51.78 million, down 7.7% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 54.0% (FY2020 to FY2025).
  • In prior years, Prokidney's Selling, General & Administrative was $56.08 million in FY2024 (+25.1%), $44.82 million in FY2023 (-36.8%), $70.94 million in FY2022 (+701.1%) and $8.86 million in FY2021 (+48.0%).
  • Quarterly Selling, General & Administrative has run from a low of $1.68 million in Q4 2023 to a high of $37.97 million in Q1 2022 over five years.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last four quarters, with growth averaging 71.8% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2024, with growth of 605.5%; the weakest was Q4 2023, with a decline of 82.0%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $11.32 million (Q1 2026), $11.44 million (Q4 2025) and $11.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Prokidney 848.66 Mn 1.96 Bn - 12.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.43 Mn
Mar 31, 2026 11.32 Mn
Dec 31, 2025 11.44 Mn
Sep 30, 2025 11.94 Mn
Jun 30, 2025 14.05 Mn
Mar 31, 2025 14.36 Mn
Dec 31, 2024 11.87 Mn
Sep 30, 2024 17.72 Mn
Jun 30, 2024 13.65 Mn
Mar 31, 2024 12.84 Mn
Dec 31, 2023 1.68 Mn
Sep 30, 2023 14.42 Mn
Jun 30, 2023 13.46 Mn
Mar 31, 2023 15.26 Mn
Dec 31, 2022 9.35 Mn
Sep 30, 2022 14.44 Mn
Jun 30, 2022 9.18 Mn
Mar 31, 2022 37.97 Mn
Dec 31, 2021 3.02 Mn
Sep 30, 2021 2.34 Mn
API Access

Prokidney Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PROK&period=max&api_key=YOUR_API_KEY